Clinical Trials Directory

Trials / Unknown

UnknownNCT03260231

Dietary Milled Seed Mix in Patients With Non-Hodgkin Lymphoma

Effects of Dietary Milled Seed Mix in Patients With Non-Hodgkin Lymphoma

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
University of Belgrade · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Recent literature data suggest beneficial effects of dietary fats in patients with cancers, in particular polyunsaturated fatty acids (PUFAs). Milled mix of flax, sesame and pumpkin seeds provides a high amount of PUFAs and a desirable n-6/n-3 PUFAs ratio.

Detailed description

Cancers are characterized by inflammation and alternations in lipid and fatty acid metabolism. Patients with non-Hodgkin lymphoma have impaired fatty acid profiles, low level of PUFAs, and high n-6/n-3 PUFAs ratio. Moreover, these changes are related to clinical outcome. Flax seeds, sesame and pumpkin seeds are rich sources of PUFAs. Dietary intake of milled mix of these seeds has been shown to decrease inflammation and improve PUFAs status in patients on hemodialysis and to decrease breast cancer risk. The study design is single-blind, controlled, randomized nutritional intervention. The participants are randomly assigned into intervention and control group before starting chemotherapy. All patients receive nutritional counseling to achieve a daily energy and protein intake according to recommended dietary allowances, with (intervention) or without (control) of milled seed mix.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMilled seed mixDietary intervention with or without seed mix

Timeline

Start date
2017-05-12
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2017-08-24
Last updated
2020-03-20

Locations

1 site across 1 country: Serbia

Source: ClinicalTrials.gov record NCT03260231. Inclusion in this directory is not an endorsement.